The article says naltrexone blocks opioid receptors in the hypothalamus, removing inhibition of pro-opiomelanocortin neurons that regulate satiety, while bupropion is a norepinephrine-dopamine reuptake inhibitor that increases alertness and reduces appetite by raising dopamine and norepinephrine in the brain's appetite-control centres
High-fat meals delay gastric emptying further, potentially compounding the medication's effect and worsening bloating
However, supplements such as psyllium husk or methylcellulose may be appropriate for patients struggling to meet fiber goals through diet alone, particularly during periods of reduced appetite
Camurus has the option to collect up to USD 290 million in upfront, development, and regulatory milestone payments, as well as USD 580 million in sales-based milestone payments and tiered mid-single digit royalties on worldwide net product sales
Meanwhile, Lars Engebretsen, the head of WADAs health, medical, and research committee, told the Norwegian Broadcasting Corporation that he believes the drugs should be banned, but mostly because they could exacerbate eating disorders
A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
